Detection of early Parkinson’s disease using 5-hydroxymethylcytosine episignatures in blood DNA
Age and Ageing · 2025
DOI: 10.1093/ageing/afaf147 ↗Kurz gefasst
Fachartikel in der Zeitschrift Age and Ageing, 2025. Verfasst von Jian-Yong Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology and Institute of Geriatric Neurology, the Second Affiliated Hospital and Yuying Children's Hospital, Wenzhou Medical Universi…. Hauptthemen laut MEDLINE: Parkinson Disease, 5-Methylcytosine, DNA Methylation, DNA. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
Background
Parkinson’s disease (PD) is a common neurodegenerative disorder. However, alterations in the blood hydroxymethylome and the potential of 5-hydroxymethylcytosine episignatures as diagnostic biomarkers for PD remain unclear.
Methods
We employed APOBEC-coupled epigenetic sequencing (ACE-seq) in a two-phase study design. In the first step, we performed single-base resolution profiling of the hydroxymethylome in a small cohort of drug-naïve PD patients and matched controls. Differentially hydroxymethylated regions (DhmRs) were identified and selected for validation. In the second step, these regions were re-sequenced in a larger cohort to develop and evaluate a diagnostic model.
Results
Initial genome-wide screening identified 16 candidate DhmRs. Although models based solely on these regions yielded modest diagnostic performance, an alternative analysis focusing on differentially hydroxymethylated cytosines within the 16 regions led to a diagnostic panel with robust performance, particularly for early PD detection. Retrospective analyses further confirmed the panel’s ability to distinguish early PD patients from controls.
Conclusions
Our study provides the first evidence that blood-based hydroxymethylome profiles are promising biomarkers for the early diagnosis of PD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology and Institute of Geriatric Neurology, the Second Affiliated Hospital and Yuying Children's Hospital, Wenzhou Medical University, Wenzhou, Zhejiang 325027, China.
- Institute of Nutrition and Diseases and Center for Research, School of Public Health, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.
- Zhejiang Key Laboratory of Intelligent Cancer Biomarker Discovery and Translation, the First Affiliated Hospital, Wenzhou Medical University, Wenzhou, Zhejiang 325015, China.
Zitieren
APA
Wang, J. Y., Song, Y. D., Zhang, D. L., Cui, L., Guo, Q., Fan, X. F., Hu, B. L., Deng, J., Wu, H. M., Zhang, X., & Zhu, J. H. (2025). Detection of early Parkinson’s disease using 5-hydroxymethylcytosine episignatures in blood DNA. Age and Ageing. https://doi.org/10.1093/ageing/afaf147
Vancouver
Wang JY, Song YD, Zhang DL, Cui L, Guo Q, Fan XF, et al. Detection of early Parkinson’s disease using 5-hydroxymethylcytosine episignatures in blood DNA. Age and Ageing. 2025. doi:10.1093/ageing/afaf147
BibTeX
@article{Wang2025,
author = {Wang, Jian-Yong and Song, Ya-Dan and Zhang, Dao-Lu and Cui, Lei and Guo, Qing and Fan, Xue-Fei and Hu, Bei-Lei and Deng, Jie and Wu, Hong-Mei and Zhang, Xiong and Zhu, Jian-Hong},
title = {Detection of early Parkinson’s disease using 5-hydroxymethylcytosine episignatures in blood DNA},
journal = {Age and Ageing},
year = {2025},
doi = {10.1093/ageing/afaf147}
}
EUVIMED